Nail histomycology. Protean aspects of a human fungal bed;Histomycologie unguéale

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 12 II, 2003, Pages 1254-1259

  Arrese, J E ^a   Quatresooz, P ^a   Pierard Franchimont C ^a   Pierard G E ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFOCAL MICROSCOPY; DIAGNOSTIC PROCEDURE; FLOW CYTOMETRY; FUNGAL CELL; FUNGAL EXAMINATION; HISTOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; ONYCHOMYCOSIS;

HUMANS; ONYCHOMYCOSIS;

EID: 0347415692     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Arrese JE, Piérard-Franchimont C, Piérard GE. Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol 1999;38(Suppl 2):1-6.
2. Mehregan DR, Gee SL. The cost effectiveness of testing for onychomycosis versus empirical treatment of onychodystrophies with oral antifungal agents. Cutis 2000;65:195-6.
3. Arrese JE, Piérard-Franchimont C, Piérard GE. A plea to bridge the gap between antifungals and the management of onychomycosis. Am J Clin Dermatol 2001;2:281-4.
4. Hull PR, Gupta AK, Summerbell RC. Onychomycosis: an evaluation of three sampling methods. J Am Acad Dermatol 1998;39:1015-7.
5. Piérard GE, Arrese JE, Pierre S, Bertrand C, Corcuff P, Lévêque JL, et al. Diagnostic microscopique des onychomycoses. Ann Dermatol Venerol 1994;121:25-9.
6. Haldane DJ, Robart E. A comparison of calcofluor white, potassium hydroxide, and culture for the laboratory diagnosis of superficial fungal infection. Diag Microbiol Infect Dis 1990;13:337-9.
7. Elewski BE. Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol 1996;35:S6-S9.
8. Piérard GE, Arrese JE, De Doncker P, Piérard-Franchimont C. Present and potential diagnostic techniques in onychomycosis. J Am Acad Dermatol 1996;34:273-7.
9. Achten G, Wanet-Rouard J. Onychomycoses in the laboratory. Mykosen 1978;21:125-7.
10. André J, Achten G. Onychomycosis. Int J Dermatol 1987;26:681-90.
11. Suarez SM, Silvers DN, Scher RK, Pearlstein HH, Auerbach R. Histologic evaluation of nail clippings for diagnosing onychomycosis. Arch Dermatol 1991;127:1517-9.
12. Arrese JE, Piérard-Franchimont C, Piérard GE. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996;18:1296-8.
13. Machler BC, Kirsner RS, Elgart GW. Routine histologic examination for the diagnosis of onychomycosis: an evaluation of sensitivity and specificity. Cutis 1998;61:217-9.
14. Gianni C, Morelli V, Cerri A, Greco C, Rossini P, Guiducci A, et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology 2001;202:283-8.
15. Piérard GE, Arrese JE, Piérard-Franchimont C, Quatresooz P. Onychomycosis under the microscope. Publ Janssen Pharmaceutica, Beerse, pp1-51, 2003.
16. Arrese JE, Piérard GE. Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology, sous presse.
17. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol 1998;139:567-71.
18. Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998;138:189-90.
19. McGinnis MR, Hilger AE. Infections caused by black fungi. Arch Dermatol 1987;12:1300-2.
20. Girmenia C, Arcese W, Micozzi A, Martino P, Bianco P, Morace G. Onychomycosis as a possible origin of disseminated Fusarium spp. infection in a patient with severe aplastic anemia. Clin Infect Dis 1992;14:1167.
21. Arrese JE, Piérard-Franchimont C, Greimers R, Piérard GE. Fungi in onychomycosis: a study by immunohistochemistry and dual flow cytometry. J Eur Acad Dermatol Venereol 1995;4:123-30.
22. Greer DL. Evolving role of nondermatophytes in onychomycosis. Int J Dermatol 1995;34:521-4.
23. Ginter G, Rieger E, Heigl K, Propst E. Increasing frequency of onychomycosis: is there a change in the spectrum of infectious agents? Mycoses 1996;39(suppl 1):118-22.
24. Arrese JE, Piérard-Franchimont C, Piérard GE. Onychomycosis and keratomycosis caused by Alternaria sp. A bipolar opportunistic infection in a wood-pulp worker on chronic steroid therapy. Am J Dermatopathol 1996;18:611-3.
25. Ellis DH, Marley JE, Watson AB, Williams TG. Significance of non-dermatophyte moulds and yeasts in onychomycosis. Dermatology 1997;194 (suppl1):40-2.
26. Summerbell RC. Epidemiology and ecology of onychomycosis. Dermatology 1997;194(suppl1):32-6.
27. Piérard GE, Piérard-Franchimont C, Arrese JE, De Doncker P. Onychomycoses caused by primary pathogens and opportunistic fungi. Chinese J Dermatol 1998;31:308-9.
28. Haneke E, Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. Int J Dermatol 1999;38:7-12.
29. Gupta AK, Cooper EA, MacDonald P, Summerbell RC. Utility of inoculum counting (Walshe and English criteria) in clinical diagnosis of onychomycosis caused by nondermatophytic filamentous fungi. J Clin Microbiol 2001;39:2115-21.
30. Scherer WP, McCreary JP, Hayes WW. The diagnosis of onychomycosis in a geriatric population: a study of 450 cases in South Florida. J Am Podiatr Med Assoc 2001;91:456-4.
31. Elewski BE. Bacterial infection in a patient with onychomycosis. J Am Acad Dermatol 1997;37:493-4.
32. Piérard-Franchimont C, De Doncker P, van de Velde V, Jacqumin P, Arrese JE, Piérard GE. Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum. Ann Soc Belge Med Trop 1995;75:211-7.
33. Perrin C, Baran R. Longitudinal melanonychia caused by Trichophyton rubrum. J Am Acad Dermatol 1994;31:311-6.
34. Jackson CJ, Barton RC, Evans EG. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J Clin Microbiol 1999;37:931-6.
35. Shuster S. Onychomycosis: making sense of the assessment of antifungal drugs. Acta Derm Venereol 1998;78:1-4.
36. Richardson MD. Effect of Lamisil and azole antifungals in experimental nail infection. Dermatology 1997;194(suppl 1):27-31.
37. Naka W, Hanyaku H, Tajima S, Harada T, Nishikawa T. Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. J Med Vet Mycol 1994;32:31-5.
38. Piérard-Franchimont C, Deleixhe-Mauhin F, Piérard GE. Dermatophytose cutanée chronique, onychomycose occulte et hamartome épidermoïde linéaire: une impasse thérapeutique. J Mycol Med 1996;6:190-4.
39. Braham C, Ezzine-Sebal N, Arrese JE, Piérard-Franchimont C, Piérard GE. Il y a sports et spores. Le pied, ses mycoses et onychomycoses. Rev Med Liège 2001;57:773-6.
40. Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen. Dermatology 2000;200:185-7.
41. Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted antifungal topical treatment (BATT) for onychomycosis. Med Mycol 2000;38:391-2.